Quick Takeaways
- Albert Cha has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $876,512.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Albert Cha
- Location
- Palo Alto, CA
- Summary
- The estimated net worth of Albert Cha is at least $876,512 dollars as of 18 Mar 2026. Albert Cha is the Director of Ascendis Pharma A/S and owns shares of Ascendis Pharma A/S (ASND) stock worth about $876.5K.
- Signature
- /s/ Michael Wolff Jensen as attorney-in-fact for Albert Cha
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Albert Cha and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Ascendis Pharma A/S ($876,512).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Albert Cha
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | Director | $876,512 | 18 Mar 2026 | ||
| KALV | KalVista Pharmaceuticals, Inc. | Director | 26 Sep 2023 |
Insider Transactions Reported by Albert Cha:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.